1 4Q25 Earnings & 2026 Guidance Presentation including Leadership Announcements and PS4.0 Introduction Public Storage Executive Speakers Tom Boyle CEO Effective April 1st Joe Fisher President & CFO Effective February 16th 2 Joe Russell President & CEO Retiring March 31st Key Takeaways | Looking Back on Our Success | Industry leadership in Operations, Core FFO growth, and Total Shareholder return – A great foundation for future success | | --- | --- | | Self-Storage Industry Outlook | Strong long-term outloo ...

Financial Data and Key Metrics Changes - The fourth quarter net sales were approximately $2.7 billion, an increase of 2.4% as reported, but a decrease of approximately 3.3% on a constant basis compared to the prior year [4] - Adjusted EPS for the quarter was $2, up approximately 3% versus the prior year, while the full year adjusted EPS was $8.96, a decrease of approximately 7.5% [5][13] - Free cash flow for the year was approximately $620 million, with stock repurchases of approximately 1.3 million shares for $149 million [5] Business Line Data and Key Metrics Changes - Global Ceramic segment had sales of just under $1.1 billion, a 6.1% increase as reported, and flat on a constant basis [13] - Flooring North America sales were $893 million, a 4.8% decrease as reported, or 6.2% on a constant basis, primarily due to a decline in the residential soft surface business [14] - Flooring Rest of the World sales were $737 million, a 6.5% increase as reported, but a 3.5% decrease on a constant basis [16] Market Data and Key Metrics Changes - Approximately 55% of sales were in the U.S., 30% in Europe, and 15% in other geographies [5] - Housing turnover in major regions remains at historical lows due to affordability challenges and economic uncertainty [5] - In Europe, high building costs and labor constraints continue to impede residential construction, although moderate recoveries have emerged in Southern and Eastern Europe [8] Company Strategy and Development Direction - The company is focusing on innovative product introductions and marketing actions to stimulate sales in soft markets [9] - Capital expenditures for 2026 are planned at approximately $480 million, focusing on product innovation and cost reduction [18] - The company anticipates benefits from product mix, productivity, and cost reductions to offset headwinds from higher energy and labor costs [28] Management's Comments on Operating Environment and Future Outlook - Management noted that while home renovation remains soft, there is optimism for improvement in existing home sales due to lower mortgage rates and increased housing supply [44] - The company expects 2026 to be a transitional year with some improvement in remodeling activity and anticipates exceeding last year's earnings [44][46] - Management highlighted that pricing pressures are likely to remain due to competitive market conditions [32] Other Important Information - The company initiated numerous restructuring actions and operational improvements that lowered its cost position [10] - The balance sheet remains strong, with gross debt of $2 billion and leverage of 0.9 times adjusted EBITDA [18] Q&A Session Summary Question: Expectations for price and mix in 2026 - Management anticipates continued pressure in the market, with inflation levels similar to 2025, but expects pricing, improved mix, and productivity to help offset inflation [32][33] Question: Inventory management ahead of spring selling season - Inventories were reduced in the fourth quarter, and management believes they are close to where they need to be, with optimism from customers for the upcoming year [39][41] Question: Outlook for 2026 and pricing dynamics - Management expects price, mix, and volume to improve, driven by pricing initiatives and a stable commercial business [57][58] Question: Impact of tariffs and pricing strategies - Tariffs range from 15%-50%, and management has taken actions to offset these costs through pricing and supply chain management [93] Question: Pricing pressure in Flooring Rest of the World - Management noted strong price competition but anticipates a slightly positive price effect as they move through the year [97]

Colliers International Group (NasdaqGS:CIGI) Q4 2025 Earnings call February 13, 2026 11:00 AM ET Speaker11Welcome to the Colliers International Fourth Quarter Year-End Investors Conference Call. Today's call is being recorded. Legal counsel requires us to advise that the discussion scheduled to take place today may contain forward-looking statements that involve known and unknown risks and uncertainties. Actual results may be materially different from any future results. Performance or achievements contempl ...

Agnico Eagle Mines (NYSE:AEM) Q4 2025 Earnings call February 13, 2026 11:00 AM ET Speaker12Good morning, ladies and gentlemen. My name is Vanessa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Agnico Eagle Mines Limited Q4 2025 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star ...

Financial Data and Key Metrics Changes - In Q4 2025, Galiano Gold produced 37,500 ounces of gold, a 15% increase from 32,000 ounces in Q3 2025, with full-year production totaling 121,000 ounces, aligning with revised guidance [4][11] - Revenue reached a record $160 million in Q4 2025, up 40% from $114 million in Q3 2025, driven by higher production and improved gold prices [5][13] - All-in sustaining cash costs decreased to $2,033 per ounce, consistent with guidance [5][15] - Adjusted net income was reported at $0.15 per share after accounting for unrealized losses on hedges [13] Business Line Data and Key Metrics Changes - Esaase mining restarted in early November 2025, with production ramping up in Q1 2026, while Nkran pre-stripping moved 23% more material compared to Q3 2025 [8][9] - The average grade of ore mined increased by 9% compared to the previous quarter, contributing to improved production metrics [8][10] Market Data and Key Metrics Changes - The company anticipates production guidance for 2026 to be between 140,000-160,000 ounces, representing a 25% increase from 2025 levels [7][12] - AISC for 2026 is projected to be between $2,000-$2,300 per ounce, influenced by a growing royalty burden due to high gold prices [15][16] Company Strategy and Development Direction - Galiano Gold plans an aggressive exploration program for 2026, focusing on expanding underground resources and reserve growth at Esaase [6][24] - The company aims to transition both Nkran and Abore to underground operations, targeting higher-value ounces [19][20] - A strong emphasis is placed on maintaining a robust cash position and leveraging a $75 million undrawn credit facility for operational investments [5][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving production targets, citing improvements in throughput and grades as key drivers [33] - The company views 2026 as a pivotal year for cash flow generation, with expectations of significant shareholder value creation [28][29] Other Important Information - The company reported no lost time injuries in Q4 2025, maintaining a strong safety record [4][8] - Exploration efforts in 2026 will include a minimum of 30,000 meters of drilling at Abore and up to 35,000 meters of conversion drilling at Esaase [24][27] Q&A Session Summary Question: What are the key execution risks to monitor with production weighted towards the second half of 2026? - Management highlighted throughput and grade improvements as critical factors for achieving production targets [33] Question: How does the downward revision to guidance impact the five-year outlook? - Management expects a slightly lower production profile in 2026 but anticipates a ramp-up in 2027 [34] Question: When should initial economic studies for the maiden underground resource at Abore and Nkran be expected? - Management aims to have initial economic studies available in 2027, following additional drilling [36][38]

Financial Data and Key Metrics Changes - In 2025, the company reported revenue growth of 8.5%, reaching $755 million compared to $696 million in 2024 [5][21] - Adjusted EBITDA improved significantly to $25 million in 2025, up from $9 million in the previous year [5][29] - For Q4 2025, total revenue was $244 million, a 2% increase from $240 million in Q4 2024 [21] Business Line Data and Key Metrics Changes - Real estate brokerage commissions for Q4 were $205 million, accounting for 84% of quarterly revenue, with 1,902 transactions totaling $11.8 billion [21][22] - Private Client transactions grew 13% in volume and 10% in transaction count, contributing 64% of brokerage revenue for the full year [23] - Financing revenue increased by 23% in 2025, totaling $104 million, driven by a 33% rise in transaction count [25] Market Data and Key Metrics Changes - The company completed nearly 9,000 transactions totaling over $50 billion in volume throughout 2025 [8] - The Private Client and Middle Market segments saw a 12% growth in transaction count and revenue [9] - The financing business continued its strong trajectory, with revenue up 23% in 2025 [10] Company Strategy and Development Direction - The company aims to expand its leadership in the private client market and penetrate the institutional segment further [18] - Investments in technology, talent retention, and acquisitions are prioritized to enhance service offerings [19] - The company is focused on leveraging AI to improve efficiency and reduce costs while maintaining the value-added role of brokers [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2026, citing improved market conditions and a more predictable valuation benchmark [16][70] - The company anticipates continued momentum in transaction activity as the market recalibrates [17][70] - Management acknowledged ongoing macroeconomic uncertainties but remains committed to a balanced capital allocation strategy [33] Other Important Information - The company maintained a strong balance sheet with nearly $400 million in cash and no debt [30] - A semiannual dividend of $0.25 per share was declared, reinforcing the company's commitment to returning capital to shareholders [31] Q&A Session Summary Question: Concerns about AI displacement in the CRE sector - Management acknowledged AI's potential to improve efficiency in manual processes but emphasized the enduring need for brokers' expertise in complex transactions [35][36][38] Question: Growth in broker count and recruitment efforts - Management confirmed that the growth in broker count was anticipated due to enhanced recruitment strategies and a focus on experienced professionals [43][46] Question: Strategic acquisitions and market uncertainty - Management indicated that market uncertainty has not deterred their acquisition strategy, and they remain optimistic about future opportunities as market conditions stabilize [49][51]

Financial Data and Key Metrics Changes - In Q4 2025, Galiano Gold produced 37,500 ounces of gold, a 15% increase from 32,000 ounces in Q3 2025, contributing to a full-year production total of 121,000 ounces, aligning with revised production guidance [4][11] - Revenue reached a record $160 million in Q4 2025, up 40% from $114 million in Q3 2025, driven by higher production and improved gold prices [5][13] - All-in sustaining cash costs decreased to $2,033 per ounce, consistent with guidance [5][15] - Adjusted net income was reported at $0.15 per share after accounting for unrealized losses on hedges [13] Business Line Data and Key Metrics Changes - Esaase mining restarted in early November 2025, with production ramping up in Q1 2026, while Nkran pre-stripping moved 23% more material compared to Q3 2025 [8][9] - The average grade of ore mined increased by 9% compared to the previous quarter, contributing to improved production metrics [8][10] Market Data and Key Metrics Changes - The company anticipates production guidance for 2026 to be between 140,000 and 160,000 ounces, representing a 25% increase from 2025 levels [7][12] - The AISC for 2026 is projected to be between $2,000 and $2,300 per ounce, influenced by a growing royalty burden due to high gold prices [15][16] Company Strategy and Development Direction - Galiano Gold plans an aggressive exploration program for 2026, focusing on expanding underground resources and reserve growth at Esaase [6][24] - The company aims to transition to underground operations at both Nkran and Abore, with a focus on higher-value underground ounces [19][28] - The strategy includes significant investment in exploration and waste stripping activities, supported by a strong cash position and a $75 million revolving credit facility [5][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving production targets, citing improvements in throughput and grades as key drivers for 2026 [32] - The company views 2026 as a pivotal year for cash flow generation, with expectations of significant shareholder value creation as fixed payments to Gold Fields conclude [17][28] Other Important Information - The company reported no lost time injuries in Q4 2025, maintaining a strong safety record [4][8] - The maiden underground mineral resource declaration is expected to reshape future resource growth potential [6][19] Q&A Session Summary Question: What are the key execution risks to monitor with production weighted towards the second half of 2026? - Management highlighted throughput and grade improvements as critical factors for achieving production targets [32] Question: How does the downward revision to guidance impact the five-year outlook? - Management expects a slightly lower production profile in 2026 but anticipates a ramp-up in 2027 [33] Question: When should initial economic studies for the maiden underground resource be expected? - Management plans to work on additional drilling and studies throughout 2026, aiming for results in 2027 [35][37]

Financial Data and Key Metrics Changes - In 2025, the company reported revenue growth of 8.5%, reaching $755 million compared to $696 million in 2024 [5][21] - Adjusted EBITDA improved significantly to $25 million in 2025, up from $9 million in the previous year [5][29] - For Q4 2025, total revenue was $244 million, a 2% increase from $240 million in Q4 2024 [21] Business Line Data and Key Metrics Changes - Real estate brokerage commissions for Q4 were $205 million, accounting for 84% of quarterly revenue, with 1,902 transactions totaling $11.8 billion [21][22] - Private Client transactions grew 13% in volume and 10% in transaction count, contributing 64% of brokerage revenue for the full year [23] - Financing revenue increased by 23% in 2025, totaling $104 million, driven by a 33% rise in transaction count [25] Market Data and Key Metrics Changes - The company completed nearly 9,000 transactions totaling over $50 billion in volume throughout 2025 [8] - The Private Client and Middle Market segments saw a 12% growth in transaction count and revenue, indicating a recovery in these areas [9] - The financing business continued its strong trajectory, with revenue up 23% in 2025 [10] Company Strategy and Development Direction - The company aims to expand its leadership in the private client market and penetrate the institutional segment further [18] - Strategic investments are being made while maintaining cost controls, focusing on technology and talent acquisition [13] - The company is exploring acquisitions to enhance its service offerings, with a strong balance sheet of nearly $400 million in cash [19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2026, citing improved market conditions and a more predictable valuation benchmark [16] - The company anticipates continued momentum in transaction activity, although macroeconomic uncertainties may moderate growth [32] - Management highlighted the importance of AI in improving operational efficiency while maintaining the value-added role of brokers [16][36] Other Important Information - The company returned $47 million to shareholders through dividends and share repurchases in 2025 [20] - A semiannual dividend of $0.25 per share was declared, payable on April 3, 2026 [31] - The company is focused on leveraging AI to enhance productivity and efficiency across various operational aspects [15] Q&A Session Summary Question: Concerns about AI displacement in the CRE sector - Management acknowledged AI's potential to improve efficiency in manual processes but emphasized the enduring need for human expertise in commercial real estate [36][38] Question: Growth in broker count and recruitment efforts - Management confirmed that the growth in broker count was anticipated due to enhanced recruitment strategies and a stronger candidate pool [43][45] Question: Strategic acquisitions and market uncertainty - Management remains committed to pursuing acquisitions despite market uncertainties, believing that the return of market clarity will enhance acquisition opportunities [50][52]

Biogen Conference Call Summary Company Overview - **Company**: Biogen (NasdaqGS:BIIB) - **Date**: February 13, 2026 - **Focus**: Immunology pipeline, specifically lupus treatments and other autoimmune diseases Key Points Industry Focus - **Lupus Treatment**: Biogen is prioritizing lupus, particularly systemic lupus erythematosus (SLE), due to its status as a major unmet medical need in drug development [2][5][11] - **Current Pipeline**: The company is developing two late-stage drugs, dapirolizumab and litifilimab, targeting lupus [1][2] Strategic Rationale - **Unmet Need**: Lupus is described as an underserved and heterogeneous disease area, with only 20%-30% of patients in the U.S. receiving biologic therapy [11][13] - **Long-term Commitment**: Biogen has been involved in lupus research for over a decade, indicating a long-term commitment to addressing this disease [5][7] Drug Development Insights - **Dapirolizumab and Litifilimab**: Both drugs aim to address limitations of existing treatments like belimumab and anifrolumab, with a focus on improving efficacy and reducing side effects [11][13] - **Patient-Centric Approach**: The company emphasizes the need for multiple treatment options due to the variability in lupus manifestations among patients [15][17] Mechanism of Action - **Litifilimab**: Targets BDCA2 receptors on plasmacytoid dendritic cells, which are involved in producing interferons that drive inflammation [19][21] - **Clinical Outcomes**: The drug has shown promise in improving overall disease control and specific manifestations like skin and joint symptoms [27][29] Clinical Trial Design - **Endpoints**: Different primary endpoints are used for dapirolizumab (BICLA response) and litifilimab (SRI-4), reflecting their unique mechanisms and patient needs [30][32] - **Durability of Effect**: Both drugs are designed to assess not only immediate efficacy but also the durability of treatment effects over time [52][54] Safety and Special Populations - **Pregnancy Considerations**: Dapirolizumab is noted for its potential safety in pregnant women, as it does not cross the placenta, which is a significant advantage given the demographic affected by lupus [63][65] Competitive Landscape - **Emerging Treatments**: The company acknowledges the upcoming readouts for other oral agents in lupus treatment, indicating a belief in a diverse treatment landscape rather than a winner-takes-all scenario [69][70] - **Future Pipeline**: Biogen is exploring additional oral therapies and has a robust early pipeline to expand treatment options [74] Broader Implications - **B-cell Biology**: The company is also interested in CD38 biology for autoimmune diseases, indicating a strategic focus on multiple indications beyond lupus [106][111] Additional Insights - **Patient Experience**: The discussion highlights the importance of addressing both physical and mental health impacts of lupus, emphasizing the need for effective treatment options that improve quality of life [29][65] - **Regulatory Engagement**: Biogen is actively engaging with regulatory agencies to explore pathways for the use of its therapies in special populations, such as pregnant women [68][69] This summary encapsulates the key discussions and insights from Biogen's conference call, focusing on their strategic direction in lupus treatment and the broader implications for the immunology field.

Financial Data and Key Metrics Changes - In 2025, the company reported revenue growth of 8.5%, reaching $755 million compared to $696 million in 2024 [5][21] - Adjusted EBITDA improved significantly to $25 million in 2025, up from $9 million in the previous year [5][28] - For Q4 2025, total revenue was $244 million, a 2% increase from $240 million in Q4 2024 [21] Business Line Data and Key Metrics Changes - Real estate brokerage commissions for Q4 were $205 million, accounting for 84% of quarterly revenue, with 1,902 transactions totaling $11.8 billion [21][22] - Private Client transactions grew 13% in volume and 10% in transaction count, contributing 64% of brokerage revenue for the full year [23] - Financing revenue increased by 23% in 2025, totaling $104 million, driven by a 33% rise in transaction count [25] Market Data and Key Metrics Changes - The company completed nearly 9,000 transactions totaling over $50 billion in volume throughout 2025 [8] - The Private Client and Middle Market segments saw a 12% growth in transaction count and revenue [9] - The financing business continued its strong trajectory, with revenue up 23% in 2025 [10] Company Strategy and Development Direction - The company aims to expand its leadership in the private client market and penetrate the institutional segment further [18] - Strategic investments are being made while maintaining cost controls, focusing on technology and talent acquisition [13] - The company is exploring acquisitions to enhance its service offerings, with a strong balance sheet of nearly $400 million in cash [19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2026, citing improved market conditions and a more predictable valuation benchmark [16] - The company anticipates continued momentum in transaction activity as the market stabilizes [17] - Management acknowledged ongoing macroeconomic uncertainties but remains cautiously optimistic about future performance [32] Other Important Information - The company returned $47 million to shareholders through dividends and share repurchases in 2025 [20] - A semiannual dividend of $0.25 per share was declared, payable on April 3, 2026 [31] Q&A Session Summary Question: Concerns about AI displacement in the CRE sector - Management acknowledged AI's potential to improve efficiency in manual processes but emphasized the importance of human expertise in the brokerage business [35][36][39] Question: Growth in broker count and recruitment efforts - Management noted that the increase in broker count was anticipated due to improved recruitment strategies and a stronger candidate pool [44][49] Question: Strategic acquisitions and market uncertainty - Management confirmed that market uncertainty has not deterred their acquisition strategy, focusing on firms that align with their culture and values [51][59]